Gritstone Bio Inc (GRTS)
0.8161
+0.08
(+10.49%)
USD |
NASDAQ |
Apr 24, 16:00
0.8161
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Profit Margin (Quarterly): -106.3K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -106.3K% |
September 30, 2023 | -10.65K% |
June 30, 2023 | -8.81K% |
March 31, 2023 | -6.27K% |
December 31, 2022 | -2.36K% |
September 30, 2022 | -6.87K% |
June 30, 2022 | -1.07K% |
March 31, 2022 | -609.4% |
December 31, 2021 | -1.67K% |
September 30, 2021 | -1.17K% |
June 30, 2021 | -883.5% |
Date | Value |
---|---|
March 31, 2021 | 19.96% |
December 31, 2020 | -2.96K% |
September 30, 2020 | -3.28K% |
June 30, 2020 | -5.30K% |
March 31, 2020 | -2.08K% |
December 31, 2019 | -3.13K% |
September 30, 2019 | -2.80K% |
June 30, 2019 | -1.84K% |
March 31, 2019 | -1.34K% |
December 31, 2018 | -1.59K% |
September 30, 2018 | -19.36K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-106.3K%
Minimum
Dec 2023
19.96%
Maximum
Mar 2021
-8.84K%
Average
-2.80K%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
Precision BioSciences Inc | -231.4% |
Humacyte Inc | -- |
Verastem Inc | -- |
BioVie Inc | -- |
Syros Pharmaceuticals Inc | -16.68K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -126.6% |
Return on Assets | -66.69% |
Return on Invested Capital | -99.53% |
Operating Margin (Quarterly) | -105.1K% |
Return on Net Operating Assets | -188.0% |